Purchase Order HHSN268201700056P

The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute awarded a $24,264 purchase order to Oxford Nanopore Technologies Inc. for the delivery of unspecified products or services. Performance will take place in New York, NY under a firm fixed price arrangement concluding on September 29, 2023. As the NIH/NHGRI supports genomic research to analyze DNA and interpret the book of life, this contract is likely to provide Oxford Nanopore's...

The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute awarded a $35,000 firm fixed price purchase order to Oxford Nanopore Technologies Inc. for a software license and device warranty to support the Oxford Nanopore Promethion 24A sequencing platform. The contract has a period of performance from January 19, 2024 through January 19, 2025. Oxford Nanopore Technologies Inc. will deliver the requested products and services as the prime...

<p>The National Heart Lung and Blood Institute awarded a purchase order to Oxford Nanopore Technologies Inc. for a nanopore direct RNA sequencing system valued at $50,105.35 on August 19, 2020. The system is to be delivered to Bethesda, Maryland. Work is firm fixed price with an ultimate completion date of August 21, 2020. The purchase order originated from a special notice posted August 7, 2020, and carried no small business set-aside.</p>

The National Human Genome Research Institute (NHGRI), a civilian agency within the National Institutes of Health (NIH), awarded a $11,508.00 firm fixed-price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The contract is for the procurement of 3 packs of 4 PROMETHION flow cell packs (RNA), with an ultimate completion date of August 7, 2024. This equipment supports NHGRI's ongoing genomics research initiatives, which utilize Oxford...

This is a $21,835.00 firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a civilian agency, to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The purpose of the award is to provide a reagent needed by Shelise Brooks for the preparation of direct RNA libraries for sequencing on the Oxford Nanopore Promethion system in support of the Collins NF_Isletbetacells project led by Dr. Mike Erdos at NHGRI. The contract...

The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $57,000 purchase order to Oxford Nanopore Technologies Inc. to procure Grid ION Mk1 sequencing devices. The one-year firm fixed price contract, running from July 2021 through July 2022, will provide the sequencing devices requested in Solicitation Number NIH-NHGRI-21-100-SOL titled &quot;To Procure Grid ION Mk1 Sequencing Device.&quot; As the parent agency of the...

The National Human Genome Research Institute (NHGRI), a civilian agency, awarded a $23,590.00 firm fixed-price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned for-profit organization, for the supply of 3 packs of 4 PromethION flow cell packs (RNA) with a period of performance through December 31, 2024. This award does not have a set-aside designation. Oxford Nanopore Technologies Inc. has secured numerous prime federal contract awards from agencies such as the National...

The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $12,500.00 firm-fixed-price purchase order to Oxford Nanopore Technologies Inc., a foreign-owned, for-profit biotechnology company, for a 12-month software license and device warranty on a GridION system. The award period runs from August 9, 2021, to August 8, 2022, and does not have a set-aside designation. Oxford Nanopore Technologies Inc. is a provider of nanopore-based...

This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Oxford Nanopore Technologies Inc., a foreign-owned for-profit biotechnology company. The $21,835 contract is for the delivery of reagents to assist investigators working to sequence unresolved regions of the human genome. The award does not have a set-aside designation. Oxford Nanopore Technologies Inc. has been awarded several...

<p>The National Institutes of Health Clinical Center awarded a purchase order to Oxford Nanopore Technologies Inc. for $14,325.00 on July 22, 2020, for scientific supplies. Place of performance is Cambridge, Massachusetts. The order has a firm fixed price and an ultimate completion date of August 21, 2020. No set-aside was used.</p>